Advanced search×

Vascular Pharmacology

Print ISSN
1537-1891
Electronic ISSN
1879-3649
Impact factor
2.174
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/15371891
Usage rank
4675
Article count
4354
Free count
8
Free percentage
0.00183739
PDFs via platforms
Rcgp, Gale, Sciencedirect, and Ingenta

  1. Cyclooxygenase Inhibition and Rosuvastatin-induced Vascular Protection in the Setting of Ischemia Reperfusion: A Human in vivo Study

    Vascular Pharmacology (2015)

    The 3-hydroxy-3-methyglutaryl coenzyme A (HMG Co-A) reductase inhibitors have preconditioning effects involving up-regulation of cyclooxygenase (COX)-2. We investigated the effect of selective and non-selective COX inhibition on rosuvastatin-mediated protection against ischemia reperfu...
  2. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 64:IFC (2015)

  3. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(3):IFC (2014)

  4. Differential mechanisms for insulin-induced relaxations in mouse posterior tibial arteries and main mesenteric arteries

    Vascular Pharmacology 63(3):173 (2014) PMID 25446161

    The characteristics of endothelium-dependent relaxations in response to insulin and acetylcholine (ACh) in the mouse posterior tibial artery (PTA) were studied on wire myograph, and compared to those in the mouse main mesenteric artery (MMA). Insulin-induced relaxation in PTA was rever...
  5. Vascular effects of the Mediterranean diet—Part II: Role of omega-3 fatty acids and olive oil polyphenols

    Vascular Pharmacology 63(3):127 (2014) PMID 25446163

    The lower occurrence of cardiovascular disease and cancer in populations around the Mediterranean basin as detected in the 1950s was correctly attributed to the peculiar dietary habits of those populations. Essentially, until the mid-20th century, typical Mediterranean diets were rich ...
  6. The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension

    Vascular Pharmacology 63(3):114 (2014) PMID 25446166

    Pulmonary arterial hypertension (PAH) is a fatal condition driven by a progressive remodelling of the small pulmonary arteries through sustained vasoconstriction, and vascular cell proliferation. This process causes a substantial reduction in luminal area increasing pulmonary vascular ...
  7. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(2):IFC (2014)

  8. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 63(1):e1 (2014)

  9. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(1):IFC (2014)

  10. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 62(3):e1 (2014)